ToddAAguileraMD

Radiation Oncology • Dallas, TX

Physician

Join to view full profile

Dr. Aguilera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aguilera's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-8525

Fax+1 214-645-8526

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2012 - 2016
University of California (San Diego) Medical CenterInternship, Internal Medicine, 2011 - 2012
University of California San Diego School of MedicineMD PhD, Biomedical Sciences, 2003 - 2011
University of California San Diego School of MedicineClass of 2011

Certifications & Licensure

CA State Medical License 2012 - Present
TX State Medical License 2016 - 2026
American Board of Radiology Radiation Oncology

Clinical Trials

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer Start of enrollment: 2020 Apr 24
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy.
Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2024-11-05
ASO Visual Abstract: Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients.
Kai Wang, John D Karalis, Ahmed Elamir, Alessandro Bifolco, Megan Wachsmann
Annals of Surgical Oncology. 2024-04-01
5 citations
Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients.
Kai Wang, John D Karalis, Ahmed Elamir, Alessandro Bifolco, Megan Wachsmann
Annals of Surgical Oncology. 2024-04-01

Journal Articles

Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence Following Radiation Therapy in Immunosuppressed Patients
Todd Aguilera, MD, Clinical Cancer Research

Press Mentions

What Does the Rectal Cancer Trial’s 100% Remission Rate Mean for Young Patients?July 21st, 2022
UTSW Receives $34 Million CPRIT Award for Cancer Research and Faculty RecruitmentSeptember 19th, 2017
Physician-Scientist Receives National Cancer Moonshot AwardAugust 17th, 2023